Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06127836 · ClinicalTrials.gov registry record · NA

Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer

A NA study of Vulvar Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
22
Enrollment target
8
Study locations

NCT06127836 is a NA study of Vulvar Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 22 participants, below the 452-participant average among 17 other Vulvar Cancer trials with a reported enrollment target (95% lower). The trial reports 8 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06127836, a NA study of Vulvar Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to compare two types of imaging for sentinel lymph node (SLN) mapping in people with early-stage vulvar cancer. The researchers will compare indocyanine green near-infrared (ICG-NIR) imaging with lymphoscintigraphy. All participants in this study will be scheduled for standard surgical treatment at Memorial Sloan Kettering Cancer Center (MSK). This surgical treatment includes SLN mapping (with both lymphoscintigraphy and ICG-NIR imaging) and SLN biopsy.

Conditions Studied

Vulvar Cancer

Interventions

  • PROCEDURE ICG guided sentinel lymph node biopsy

Study Locations (8)

New York

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale

Texas

  • Houston Methodist Cancer Center (Data Collection Only) - Houston

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2023-11-06
Est. Completion 2026-11
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06127836

The ClinicalTrials.gov registry entry for NCT06127836 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 17 other Vulvar Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vulvar Cancer appearing as the primary indexed condition, and to 1 intervention - of which ICG guided sentinel lymph node biopsy is the first listed.

NCT06127836 reports 8 study locations spanning 3 distinct geographic areas - top geographies include New York, New Jersey, Texas.

Frequently Asked Questions

What is clinical trial NCT06127836 about?

NCT06127836 is a clinical study titled "Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer". The purpose of this study is to compare two types of imaging for sentinel lymph node (SLN) mapping in people with early-stage vulvar cancer. The researchers will compare indocyanine green near-infrared (ICG-NIR) imaging with lymphoscintigraphy. All participants in this study will be scheduled for st...

What is the current status of trial NCT06127836?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2023-11-06. Estimated completion is 2026-11.

What conditions does trial NCT06127836 study?

This clinical trial studies the following conditions: Vulvar Cancer.

What interventions are being tested in trial NCT06127836?

The interventions under investigation include: ICG guided sentinel lymph node biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT06127836?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06127836 being conducted?

This trial has 8 study locations across New Jersey, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vulvar Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vulvar Cancer

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.